Autolus Therapeutics plc American Depositary Share (AUTL)
Autolus Therapeutics plc American Depositary Share
XNAS:AUTL
1.55
$1.63 - 1.00
$1.53 - 9,727.00
$1.52
$1.59
$1.58
$1.57
3.08
1.11
1591921
5217727
240335903.84
Chart
TendieTensor AI Analysis
Company
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Fundamentals
647
-1.840000
2.100050
-0.3
100
BBG00KVT05R6
BBG00KVT06G6
266.14M
266.14M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own AUTL. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.